Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2026 16:49 ET | Source: Boundless Bio, Inc.

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies...
April 17, 2026 16:05 ET | Source: Theriva Biologics, Inc.

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

- Tumor reponse, biomarker, and subgroup analyses from the VIRAGE Phase 2b clinical trial support a VCN-01 immune-mediated mode of action and demonstrate improved outcomes in VCN-01 treated patients...
April 17, 2026 16:01 ET | Source: Olema Oncology

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
April 17, 2026 16:01 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

SAN DIEGO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a...
April 17, 2026 16:01 ET | Source: Xilio Therapeutics, Inc.

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

XTX601 demonstrated protease-dependent, tumor-selective activation and potent anti-tumor activity in multiple preclinical models Consistent with Xilio’s clinically-validated masking technology,...
April 17, 2026 14:40 ET | Source: JimStoppani.com

JimStoppani.com Announces Summer Shred Challenge with $25,000 Grand Prize

Westlake Village, CA, April 17, 2026 (GLOBE NEWSWIRE) -- JimStoppani.com, a digital fitness platform founded by exercise scientist Dr. Jim Stoppani, announced the launch of its Summer Shred...
April 17, 2026 13:57 ET | Source: Opticore Eye Group

Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026

Riverside, California, United States, April 17, 2026 (GLOBE NEWSWIRE) -- Opticore Eye Group, a leader in comprehensive eye care, is thrilled to announce the launch of its innovative Contact Lens...
April 17, 2026 13:20 ET | Source: Spherix Global Insights

Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity

Exton, PA, April 17, 2026 (GLOBE NEWSWIRE) -- New data from Spherix Global Insights’ Launch Dynamix™ service indicate that rebalancing agents are continuing to establish a foothold in hemophilia...